{
    "clinical_study": {
        "@rank": "152977", 
        "arm_group": {
            "arm_group_label": "liver transplantation recipients", 
            "description": "adult liver transplantation recipients (>=20 years at the date of surgery)"
        }, 
        "biospec_descr": {
            "textblock": "no biospecimens are to be retained"
        }, 
        "biospec_retention": "None Retained", 
        "brief_summary": {
            "textblock": "Conventionally, the outcome of liver transplantation is usually reported in terms of graft\n      and patient survival, medical and surgical complications, but lack of health-related quality\n      of life (HRQOL) that might be associated with immunosuppression complications (e.g.,\n      diabetes, hypertension, dyslipidemia, obesity, metabolic syndrome, cardiovascular disease,\n      renal dysfunction, osteoporosis, and de novo malignancy), disease recurrence, and rejections\n      after transplantation."
        }, 
        "brief_title": "Uses of Immunosuppression Therapy in Patients With Liver Transplantation", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Evidence of Liver Transplantation", 
        "detailed_description": {
            "textblock": "Specific aims are proposed to achieve in this study:\n\n        1. To compare graft and patient survival rate, incidence of treatment-related adverse\n           effects between different patterns of immunosuppression combination among patients\n           received post-liver transplant care in Kaohsiung Chang Gung Memorial Hospital (KCGMH),\n           Taiwan.\n\n        2. To quantify the long-term health impacts of immunosuppressive regimens on\n           quality-adjusted life expectancy (QALE), the loss-of-QALE relating to immunosuppression\n           therapy, and types of transplantation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Aim 1:\n\n        Inclusion Criteria:\n\n          -  age at liver transplantation is at least 20 years\n\n        Aim 2:\n\n        Inclusion Criteria:\n\n          -  age at liver transplantation is at least 20 years\n\n        Exclusion Criteria:\n\n          -  deceased patient\n\n          -  cannot obtain inform consent\n\n          -  age <20 years"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Study subjects: Patients who had liver transplantation in Kaohsiung Chang Gung Memorial\n        Hospital"
            }
        }, 
        "enrollment": {
            "#text": "1088", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01834690", 
            "org_study_id": "102-0582C"
        }, 
        "intervention_browse": {
            "mesh_term": "Immunosuppressive Agents"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Liver transplantation/epidemiology", 
            "Liver transplantation/pharmacology", 
            "Health status/drug effects", 
            "Agents, immunosuppressive agents"
        ], 
        "lastchanged_date": "December 26, 2013", 
        "location": {
            "contact": {
                "last_name": "Chien-Ning Hsu, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Kaohsiung", 
                    "country": "Taiwan", 
                    "zip": "833"
                }, 
                "name": "Kaohsiung Chang Gung Memorial Hospital"
            }, 
            "investigator": {
                "last_name": "Chien-Ning Hsu, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_groups": "1", 
        "official_title": "Trends of Immunosuppression Therapy and Their Effectiveness in Patients With Liver Transplantation", 
        "other_outcome": {
            "description": "QALE:quality-adjusted weight for each health status (measured by EQ-5D)will be multiplied by the survival time and then summed to calculate the number of QALE.\nLoss-of QALE: the life time expectancy (survival function) for thes study cohort will be compared with Taiwan general population of subjects who are age- and gender-matched with study subjects.", 
            "measure": "quality-adjusted life expectancy (QALE), loss-of-QALE", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "overall_contact": {
            "last_name": "Chien-Ning Hsu, PhD", 
            "phone": "(07)7317123", 
            "phone_ext": "6134"
        }, 
        "overall_official": {
            "affiliation": "Kaohsiung Chang Gung Memorial Hospital", 
            "last_name": "Chien-Ning Hsu, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Taiwan : Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patient will be followed from the date of liver transplantation to the occurence of outcome event for 5 years", 
            "measure": "incidence of graft and patient mortality, treatment-related complications", 
            "safety_issue": "Yes", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01834690"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chang Gung Memorial Hospital", 
            "investigator_full_name": "Chien-Ning Hsu", 
            "investigator_title": "Clinical Pharmacist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "health-related quality of life will be measured by EQ-5D-5L and 15D", 
            "measure": "health-related quality of life", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "source": "Chang Gung Memorial Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chang Gung Memorial Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Observational Model: Cohort", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}